56 studies found for:    "VLDLR-associated cerebellar hypoplasia" [DISEASE] OR "Cerebellar Ataxia" [DISEASE] OR NCT00041600 [ID-NUMBER]
Show Display Options
Download search resultsDownload the search results for:
"VLDLR-associated cerebellar hypoplasia" [DISEASE] OR "Cerebellar Ataxia" [DISEASE] OR NCT00041600 [ID-NUMBER] (56 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia
Conditions: Hereditary Ataxia;   Multiple Sclerosis;   Cerebellar Ataxia
Interventions: Drug: Riluzole;   Other: placebo
2 Completed Gluten-Free Diet in Patients With Gluten Sensitivity and Cerebellar Ataxia
Conditions: Celiac Disease;   Cerebellar Ataxia;   Healthy
Intervention:
3 Recruiting Clinical Study to Evaluate the Safety and Efficacy BMMNC in Cerebellar Ataxia
Condition: Cerebellar Ataxia
Intervention: Biological: Intravenous transfer of of Bone Marrow derived Mono Nuclear Stem Cell (BMMNCs)
4 Unknown  SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Conditions: Cerebellar Ataxias;   Spastic Paraplegias
Intervention:
5 Enrolling by invitation A New Method to Treat Hereditary Cerebellar Ataxia - Umbilical Cord Mesenchymal Stem Cells Transplantation
Condition: Hereditary Cerebellar Ataxia.
Intervention: Other: stem cell transplantation
6 Completed Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells
Condition: Cerebellar Ataxia
Intervention: Biological: Allogeneic adult adipose-derived mesenchymal stem cells
7 Active, not recruiting Exercise Training Program for Cerebellar Ataxia
Condition: Cerebellar Ataxia
Intervention: Behavioral: Home exercise program
8 Unknown  Efficacy of Riluzole in Hereditary Cerebellar Ataxia
Condition: Cerebellar Ataxia
Interventions: Drug: riluzole;   Other: Placebo comparator
9 Recruiting Phenotypic and Genotypic Studies in Congenital and Early Onset Ataxias
Conditions: Congenital Cerebellar Ataxias;   Early-onset Cerebellar Ataxias
Intervention: Genetic: blood sample
10 Active, not recruiting Biomarkers in Autosomal Dominant Cerebellar Ataxia
Conditions: Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia, Autosomal Recessive 3;   Episodic Ataxia, Type 7
Intervention: Other: metabolic and imaging biomarkers in SCA1,2,3 and 7 patients
11 Recruiting Transcranial Magnetic Stimulation in Spino-Cerebellar Ataxia
Condition: Spinocerebellar Ataxia
Intervention: Device: Transcranial Magnetic Stimulation
12 Completed A Randomized Controlled Single-Blind Study of the Effects of Instrument-Applied Spinal Manipulative Therapy on Postural Control
Condition: Disequilibrium
Intervention: Device: Pro Adjuster
13 Recruiting Human Epilepsy Genetics--Neuronal Migration Disorders Study
Conditions: Epilepsy;   Seizures;   Cognition Disorders;   Neuronal Migration Disorders
Intervention:
14 Completed
Has Results
Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium
Conditions: Vestibular Diseases;   Labyrinth Diseases;   Ear Diseases;   Otorhinolaryngologic Diseases;   Traumatic Brain Injury
Interventions: Device: Usual care physical therapy plus SEMD;   Other: Usual care physical therapy only
15 Completed Mapping of End Stage Renal Disease Genetic Susceptibility in African Americans by Admixture Linkage Disequilibrium
Condition: End Stage Renal Disease (ESRD)
Intervention:
16 Completed High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration
Condition: Spinocerebellar Degenerations
Intervention: Drug: high-dose intravenous immunoglobulin (IVIG)
17 Completed Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3
Condition: Spinocerebellar Ataxia Type 3
Interventions: Drug: varenicline;   Drug: placebo
18 Recruiting Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias
Conditions: Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 6
Intervention: Genetic: All Participants
19 Completed Safety and Tolerability of Lithium in Spinocerebellar Ataxia 2 (SCA2)
Condition: SPINOCEREBELLAR ATAXIA 2
Intervention: Drug: LITHIUM CARBONATE
20 Completed Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)
Condition: Hereditary Ataxia
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years